Clinical Trials Browser

Phase 1/2 × Uveal Melanoma × Magnetic Resonance Spectroscopy × Clear all

NCT05677373 2023-08-18

Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma

Phase 1/2 Withdrawn

Uveal Melanoma